The drug was approved to treat patients who have already received chemotherapy under an accelerated approval process after a ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

BENGALURU: Biopharmaceutical company AstraZeneca on Thursday announced the expansion of its global hub in Bengaluru with Rs ...

AstraZeneca invests Rs 166 crore in a new Bengaluru Global Hub focused on AI-driven healthcare solutions, creating 400 new ...

Biopharmaceutical firm AstraZeneca on Thursday said it has expanded its global hub in Bengaluru with an investment of Rs 166 ...

Global bio-pharmaceutical company AstraZeneca has established its state-of-the-art Global Hub in Bengaluru investing Rs 166 ...

The average brokerage recommendation (ABR) for Astrazeneca (AZN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly ...

This expansion will support the company’s AI-powered innovation across R&D, global business services, IT, and digital health.

AstraZeneca (LSE:AZN) recently announced the U.S. FDA accelerated approval of Datroway for treating advanced EGFR-mutated non ...

AstraZeneca has expanded its Bengaluru hub with a Rs 166 crore investment, creating 400 jobs to enhance R&D, global services, ...

AstraZeneca has launched a new Global Hub in Bengaluru, investing Rs 166 crore for AI healthcare solutions. This move aims to ...